News
StockStory.org on MSN1d
MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio DiversificationGlobal pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results , but sales fell by 1.6% year on year to $15.53 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback